| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | complement component C3b binding | 3.18e-05 | 12 | 107 | 3 | GO:0001851 | |
| GeneOntologyMolecularFunction | opsonin binding | 3.16e-04 | 25 | 107 | 3 | GO:0001846 | |
| GeneOntologyMolecularFunction | integrin binding | 3.62e-04 | 175 | 107 | 6 | GO:0005178 | |
| GeneOntologyMolecularFunction | fibrinogen binding | 4.21e-04 | 6 | 107 | 2 | GO:0070051 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 4.70e-04 | 120 | 107 | 5 | GO:0004222 | |
| GeneOntologyMolecularFunction | complement binding | 6.63e-04 | 32 | 107 | 3 | GO:0001848 | |
| GeneOntologyMolecularFunction | calcium ion binding | ESYT1 ADAMTS13 CD320 SVEP1 JAG2 THBS1 GJB2 CAMKK2 MEGF8 LRP2 LTBP2 FBN3 | 6.75e-04 | 749 | 107 | 12 | GO:0005509 |
| GeneOntologyMolecularFunction | interleukin-17 receptor activity | 7.80e-04 | 8 | 107 | 2 | GO:0030368 | |
| GeneOntologyMolecularFunction | virus receptor activity | 1.13e-03 | 85 | 107 | 4 | GO:0001618 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 1.13e-03 | 85 | 107 | 4 | GO:0038024 | |
| GeneOntologyMolecularFunction | exogenous protein binding | 1.18e-03 | 86 | 107 | 4 | GO:0140272 | |
| GeneOntologyMolecularFunction | RNA polymerase II CTD heptapeptide repeat kinase activity | 1.24e-03 | 10 | 107 | 2 | GO:0008353 | |
| GeneOntologyMolecularFunction | growth factor binding | 1.53e-03 | 156 | 107 | 5 | GO:0019838 | |
| GeneOntologyMolecularFunction | monosaccharide binding | 1.71e-03 | 95 | 107 | 4 | GO:0048029 | |
| GeneOntologyMolecularFunction | insulin-like growth factor I binding | 2.13e-03 | 13 | 107 | 2 | GO:0031994 | |
| GeneOntologyBiologicalProcess | apoptotic cell clearance | 4.90e-06 | 48 | 107 | 5 | GO:0043277 | |
| GeneOntologyBiologicalProcess | negative regulation of complement activation, classical pathway | 7.46e-06 | 8 | 107 | 3 | GO:0045959 | |
| GeneOntologyBiologicalProcess | blood coagulation | 8.56e-06 | 260 | 107 | 9 | GO:0007596 | |
| GeneOntologyBiologicalProcess | coagulation | 1.03e-05 | 266 | 107 | 9 | GO:0050817 | |
| GeneOntologyBiologicalProcess | hemostasis | 1.09e-05 | 268 | 107 | 9 | GO:0007599 | |
| GeneOntologyBiologicalProcess | regulation of complement activation | 1.10e-05 | 27 | 107 | 4 | GO:0030449 | |
| GeneOntologyBiologicalProcess | regulation of complement activation, classical pathway | 1.59e-05 | 10 | 107 | 3 | GO:0030450 | |
| GeneOntologyBiologicalProcess | negative regulation of humoral immune response mediated by circulating immunoglobulin | 2.89e-05 | 12 | 107 | 3 | GO:0002924 | |
| GeneOntologyBiologicalProcess | phagocytosis, engulfment | 2.95e-05 | 69 | 107 | 5 | GO:0006911 | |
| GeneOntologyBiologicalProcess | complement activation | 3.17e-05 | 70 | 107 | 5 | GO:0006956 | |
| GeneOntologyBiologicalProcess | negative regulation of complement activation | 4.74e-05 | 14 | 107 | 3 | GO:0045916 | |
| GeneOntologyBiologicalProcess | positive regulation of platelet activation | 4.74e-05 | 14 | 107 | 3 | GO:0010572 | |
| GeneOntologyBiologicalProcess | plasma membrane invagination | 5.34e-05 | 78 | 107 | 5 | GO:0099024 | |
| GeneOntologyBiologicalProcess | engulfment of apoptotic cell | 5.90e-05 | 15 | 107 | 3 | GO:0043652 | |
| GeneOntologyBiologicalProcess | negative regulation of B cell mediated immunity | 7.24e-05 | 16 | 107 | 3 | GO:0002713 | |
| GeneOntologyBiologicalProcess | negative regulation of immunoglobulin mediated immune response | 7.24e-05 | 16 | 107 | 3 | GO:0002890 | |
| GeneOntologyBiologicalProcess | blood coagulation, fibrin clot formation | 8.75e-05 | 17 | 107 | 3 | GO:0072378 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | TSPAN12 CFH FLNA ADAM15 NTN3 DVL3 LAMC2 LAMC3 AHDC1 PGR JAG2 THBS1 MEGF8 EGFR PKD1 LRP2 RELT MEGF11 | 8.81e-05 | 1269 | 107 | 18 | GO:0009887 |
| GeneOntologyBiologicalProcess | membrane invagination | 9.01e-05 | 87 | 107 | 5 | GO:0010324 | |
| GeneOntologyBiologicalProcess | phagocytosis | 9.17e-05 | 274 | 107 | 8 | GO:0006909 | |
| GeneOntologyBiologicalProcess | endocytosis | SIGLEC12 MRC1 XKR6 CD320 ITGB3 ABCA7 THBS1 SIGLEC7 STON2 LRP2 RAB11FIP5 C4BPB ARHGAP27 PEAR1 | 9.51e-05 | 827 | 107 | 14 | GO:0006897 |
| GeneOntologyBiologicalProcess | regulation of body fluid levels | 1.02e-04 | 442 | 107 | 10 | GO:0050878 | |
| GeneOntologyBiologicalProcess | complement activation, alternative pathway | 1.24e-04 | 19 | 107 | 3 | GO:0006957 | |
| GeneOntologyBiologicalProcess | negative regulation of humoral immune response | 1.24e-04 | 19 | 107 | 3 | GO:0002921 | |
| GeneOntologyBiologicalProcess | platelet activation | 1.76e-04 | 158 | 107 | 6 | GO:0030168 | |
| GeneOntologyBiologicalProcess | regulation of humoral immune response mediated by circulating immunoglobulin | 1.95e-04 | 22 | 107 | 3 | GO:0002923 | |
| GeneOntologyBiologicalProcess | protein activation cascade | 2.54e-04 | 24 | 107 | 3 | GO:0072376 | |
| GeneOntologyBiologicalProcess | regulation of phagocytosis, engulfment | 2.54e-04 | 24 | 107 | 3 | GO:0060099 | |
| GeneOntologyBiologicalProcess | negative regulation of phagocytosis, engulfment | 2.64e-04 | 5 | 107 | 2 | GO:0060101 | |
| GeneOntologyBiologicalProcess | natural killer cell differentiation involved in immune response | 2.64e-04 | 5 | 107 | 2 | GO:0002325 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell differentiation involved in immune response | 2.64e-04 | 5 | 107 | 2 | GO:0032826 | |
| GeneOntologyBiologicalProcess | regulation of humoral immune response | 2.67e-04 | 60 | 107 | 4 | GO:0002920 | |
| GeneOntologyBiologicalProcess | regulation of membrane invagination | 2.87e-04 | 25 | 107 | 3 | GO:1905153 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | 3.72e-04 | 619 | 107 | 11 | GO:0002009 | |
| GeneOntologyBiologicalProcess | negative regulation of membrane invagination | 3.95e-04 | 6 | 107 | 2 | GO:1905154 | |
| GeneOntologyBiologicalProcess | activation of membrane attack complex | 3.95e-04 | 6 | 107 | 2 | GO:0001905 | |
| GeneOntologyBiologicalProcess | homotypic cell-cell adhesion | 4.72e-04 | 124 | 107 | 5 | GO:0034109 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | FLNA DVL3 PLXNB2 ITGB3 AHDC1 PGR JAG2 MEGF8 EGFR PKD1 LRP2 KDF1 | 5.14e-04 | 750 | 107 | 12 | GO:0048729 |
| GeneOntologyBiologicalProcess | regulation of complement activation, alternative pathway | 5.50e-04 | 7 | 107 | 2 | GO:0030451 | |
| GeneOntologyBiologicalProcess | apolipoprotein A-I-mediated signaling pathway | 5.50e-04 | 7 | 107 | 2 | GO:0038027 | |
| GeneOntologyBiologicalProcess | gap junction-mediated intercellular transport | 5.50e-04 | 7 | 107 | 2 | GO:1990349 | |
| GeneOntologyCellularComponent | cell surface | SIGLEC12 CFH MRC1 ISLR2 UPK1A ADAM15 IL17RC ADAMTS13 CR1 PLXNB2 ADGRA2 ITGB3 ABCA7 THBS1 SIGLEC7 EGFR ADAMTS7 PKD1 LRP2 SCART1 | 7.89e-07 | 1111 | 107 | 20 | GO:0009986 |
| GeneOntologyCellularComponent | extracellular matrix | NTN3 LAMC2 LAMC3 ADAMTS13 PLXNB2 SSPOP SVEP1 ADAMTS10 THBS1 FCGBP ADAMTS7 ADAMTS20 LTBP2 FBN3 | 6.45e-06 | 656 | 107 | 14 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | NTN3 LAMC2 LAMC3 ADAMTS13 PLXNB2 SSPOP SVEP1 ADAMTS10 THBS1 FCGBP ADAMTS7 ADAMTS20 LTBP2 FBN3 | 6.68e-06 | 658 | 107 | 14 | GO:0030312 |
| GeneOntologyCellularComponent | ruffle membrane | 2.35e-04 | 108 | 107 | 5 | GO:0032587 | |
| MousePheno | petechiae | 3.34e-05 | 11 | 84 | 3 | MP:0008816 | |
| MousePheno | abnormal cilary zonule morphology | 3.57e-05 | 2 | 84 | 2 | MP:0014176 | |
| MousePheno | abnormal blood vessel morphology | TSPAN12 CFH FLNA ADAM15 PFKM CD320 CR1 ADGRA2 ITGB3 AHDC1 LACTB PGR THBS1 GJB2 MEGF8 EGFR ADAMTS7 SETD5 CDK13 PKD1 LRP2 SLC14A2 | 4.00e-05 | 1472 | 84 | 22 | MP:0001614 |
| MousePheno | heart left ventricle hypertrophy | 4.32e-05 | 65 | 84 | 5 | MP:0002625 | |
| MousePheno | abnormal epidermal-dermal junction morphology | 4.43e-05 | 12 | 84 | 3 | MP:0011159 | |
| MousePheno | abnormal uvea morphology | 9.80e-05 | 241 | 84 | 8 | MP:0005197 | |
| MousePheno | abnormal kidney morphology | CFH PHRF1 DVL3 KCP LAMC2 IL17RC CR1 PLXNB2 ITGB3 ABCA7 TYR GJA8 THBS1 MEGF8 EGFR SETD5 CDK13 PKD1 LRP2 SLC14A2 | 1.27e-04 | 1363 | 84 | 20 | MP:0002135 |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | FLNA SPEG DVL3 LAMC2 CHD4 CR1 ADGRA2 AHDC1 JAG2 TYR GJB2 MEGF8 EGFR SETD5 CDK13 HES7 PKD1 LRP2 KDF1 | 1.50e-04 | 1269 | 84 | 19 | MP:0011111 |
| MousePheno | abnormal cardiac outflow tract development | 1.53e-04 | 134 | 84 | 6 | MP:0006126 | |
| MousePheno | abnormal snout morphology | 1.53e-04 | 257 | 84 | 8 | MP:0000443 | |
| MousePheno | lethality throughout fetal growth and development, complete penetrance | 1.79e-04 | 263 | 84 | 8 | MP:0011099 | |
| MousePheno | abnormal anterior uvea morphology | 1.91e-04 | 199 | 84 | 7 | MP:0005194 | |
| MousePheno | skin detachment | 2.12e-04 | 4 | 84 | 2 | MP:0009827 | |
| MousePheno | small snout | 2.26e-04 | 144 | 84 | 6 | MP:0030190 | |
| MousePheno | abnormal cardiovascular development | FLNA SPEG DVL3 CHD4 PFKM ADGRA2 ITGB3 AHDC1 THBS1 MEGF8 ADAMTS7 SETD5 PKD1 LRP2 | 2.79e-04 | 802 | 84 | 14 | MP:0002925 |
| MousePheno | omphalocele | 2.84e-04 | 53 | 84 | 4 | MP:0003052 | |
| MousePheno | abnormal jaw morphology | 3.18e-04 | 530 | 84 | 11 | MP:0000454 | |
| MousePheno | abnormal heart left ventricle wall morphology | 3.19e-04 | 99 | 84 | 5 | MP:0031533 | |
| MousePheno | cleft palate | 3.39e-04 | 289 | 84 | 8 | MP:0000111 | |
| MousePheno | abnormal pulse pressure | 3.53e-04 | 5 | 84 | 2 | MP:0003882 | |
| MousePheno | oral cleft | 3.55e-04 | 291 | 84 | 8 | MP:0021164 | |
| MousePheno | abnormal heart ventricle wall morphology | 3.98e-04 | 296 | 84 | 8 | MP:0031532 | |
| Domain | EGF_1 | ADAM15 NTN3 LAMC2 LAMC3 SSPOP ITGB3 SVEP1 JAG2 THBS1 MEGF8 LRP2 LTBP2 MEGF11 FBN3 PEAR1 | 1.32e-11 | 255 | 105 | 15 | PS00022 |
| Domain | EGF_2 | ADAM15 NTN3 LAMC2 LAMC3 SSPOP ITGB3 SVEP1 JAG2 THBS1 MEGF8 LRP2 LTBP2 MEGF11 FBN3 PEAR1 | 2.28e-11 | 265 | 105 | 15 | PS01186 |
| Domain | EGF-like_CS | ADAM15 NTN3 LAMC2 LAMC3 ITGB3 SVEP1 JAG2 THBS1 MEGF8 LRP2 LTBP2 MEGF11 FBN3 PEAR1 | 2.26e-10 | 261 | 105 | 14 | IPR013032 |
| Domain | EGF | ADAM15 LAMC2 LAMC3 SVEP1 JAG2 THBS1 FCGBP MEGF8 LRP2 LTBP2 MEGF11 FBN3 PEAR1 | 7.13e-10 | 235 | 105 | 13 | SM00181 |
| Domain | EGF-like_dom | ADAM15 LAMC2 LAMC3 SVEP1 JAG2 THBS1 FCGBP MEGF8 LRP2 LTBP2 MEGF11 FBN3 PEAR1 | 1.45e-09 | 249 | 105 | 13 | IPR000742 |
| Domain | Sushi | 1.58e-08 | 52 | 105 | 7 | PF00084 | |
| Domain | Growth_fac_rcpt_ | 1.81e-08 | 156 | 105 | 10 | IPR009030 | |
| Domain | CCP | 2.07e-08 | 54 | 105 | 7 | SM00032 | |
| Domain | SUSHI | 2.68e-08 | 56 | 105 | 7 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 3.04e-08 | 57 | 105 | 7 | IPR000436 | |
| Domain | Laminin_EGF | 3.89e-08 | 35 | 105 | 6 | PF00053 | |
| Domain | EGF_Lam | 3.89e-08 | 35 | 105 | 6 | SM00180 | |
| Domain | EGF_extracell | 4.38e-08 | 60 | 105 | 7 | IPR013111 | |
| Domain | EGF_2 | 4.38e-08 | 60 | 105 | 7 | PF07974 | |
| Domain | Laminin_EGF | 6.52e-08 | 38 | 105 | 6 | IPR002049 | |
| Domain | EGF_3 | ADAM15 SSPOP SVEP1 JAG2 THBS1 MEGF8 LRP2 LTBP2 MEGF11 FBN3 PEAR1 | 8.73e-08 | 235 | 105 | 11 | PS50026 |
| Domain | EGF_CA | 5.41e-07 | 86 | 105 | 7 | PF07645 | |
| Domain | TIL_dom | 9.04e-07 | 14 | 105 | 4 | IPR002919 | |
| Domain | TSP_1 | 1.43e-06 | 63 | 105 | 6 | PF00090 | |
| Domain | TSP1 | 1.73e-06 | 65 | 105 | 6 | SM00209 | |
| Domain | TSP1_rpt | 1.73e-06 | 65 | 105 | 6 | IPR000884 | |
| Domain | TSP1 | 1.73e-06 | 65 | 105 | 6 | PS50092 | |
| Domain | VWC | 2.21e-06 | 38 | 105 | 5 | SM00214 | |
| Domain | DISINTEGRIN_1 | 2.87e-06 | 40 | 105 | 5 | PS00427 | |
| Domain | Reprolysin | 2.87e-06 | 40 | 105 | 5 | PF01421 | |
| Domain | ADAM_MEPRO | 2.87e-06 | 40 | 105 | 5 | PS50215 | |
| Domain | DISINTEGRIN_2 | 2.87e-06 | 40 | 105 | 5 | PS50214 | |
| Domain | Peptidase_M12B | 2.87e-06 | 40 | 105 | 5 | IPR001590 | |
| Domain | Disintegrin_dom | 3.26e-06 | 41 | 105 | 5 | IPR001762 | |
| Domain | VWC_out | 3.43e-06 | 19 | 105 | 4 | SM00215 | |
| Domain | VWF_dom | 3.68e-06 | 42 | 105 | 5 | IPR001007 | |
| Domain | EGF_CA | 5.72e-06 | 122 | 105 | 7 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 6.37e-06 | 124 | 105 | 7 | IPR001881 | |
| Domain | Peptidase_M12B_ADAM-TS | 9.19e-06 | 24 | 105 | 4 | IPR013273 | |
| Domain | hEGF | 1.74e-05 | 28 | 105 | 4 | PF12661 | |
| Domain | EGF_Ca-bd_CS | 1.79e-05 | 97 | 105 | 6 | IPR018097 | |
| Domain | EGF_CA | 2.01e-05 | 99 | 105 | 6 | PS01187 | |
| Domain | ASX_HYDROXYL | 2.12e-05 | 100 | 105 | 6 | PS00010 | |
| Domain | EGF_LAM_2 | 2.31e-05 | 30 | 105 | 4 | PS50027 | |
| Domain | EGF_LAM_1 | 2.31e-05 | 30 | 105 | 4 | PS01248 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 2.96e-05 | 106 | 105 | 6 | IPR000152 | |
| Domain | Unchr_dom_Cys-rich | 4.74e-05 | 13 | 105 | 3 | IPR014853 | |
| Domain | C8 | 4.74e-05 | 13 | 105 | 3 | SM00832 | |
| Domain | VWFC_1 | 4.84e-05 | 36 | 105 | 4 | PS01208 | |
| Domain | VWFC_2 | 6.01e-05 | 38 | 105 | 4 | PS50184 | |
| Domain | Peptidase_M12B_N | 6.67e-05 | 39 | 105 | 4 | IPR002870 | |
| Domain | Pep_M12B_propep | 6.67e-05 | 39 | 105 | 4 | PF01562 | |
| Domain | EGF | 7.80e-05 | 126 | 105 | 6 | PF00008 | |
| Domain | VWD | 9.17e-05 | 16 | 105 | 3 | SM00216 | |
| Domain | VWF_type-D | 9.17e-05 | 16 | 105 | 3 | IPR001846 | |
| Domain | VWFD | 9.17e-05 | 16 | 105 | 3 | PS51233 | |
| Domain | VWD | 9.17e-05 | 16 | 105 | 3 | PF00094 | |
| Domain | MetalloPept_cat_dom | 9.31e-05 | 81 | 105 | 5 | IPR024079 | |
| Domain | - | 9.31e-05 | 81 | 105 | 5 | 3.40.390.10 | |
| Domain | IL-17_rcpt_C/E_N | 9.36e-05 | 3 | 105 | 2 | IPR027841 | |
| Domain | IL17_R_N | 9.36e-05 | 3 | 105 | 2 | PF15037 | |
| Domain | EMI | 1.11e-04 | 17 | 105 | 3 | PS51041 | |
| Domain | LDLRA_1 | 1.52e-04 | 48 | 105 | 4 | PS01209 | |
| Domain | LDLRA_2 | 1.64e-04 | 49 | 105 | 4 | PS50068 | |
| Domain | CUB | 2.23e-04 | 53 | 105 | 4 | PS01180 | |
| Domain | ZINC_PROTEASE | 2.29e-04 | 98 | 105 | 5 | PS00142 | |
| Domain | ADAM_spacer1 | 2.82e-04 | 23 | 105 | 3 | IPR010294 | |
| Domain | ADAM_spacer1 | 2.82e-04 | 23 | 105 | 3 | PF05986 | |
| Domain | CUB_dom | 2.96e-04 | 57 | 105 | 4 | IPR000859 | |
| Domain | TB | 6.45e-04 | 7 | 105 | 2 | PF00683 | |
| Domain | LAMININ_IVA | 8.57e-04 | 8 | 105 | 2 | PS51115 | |
| Domain | Laminin_B | 8.57e-04 | 8 | 105 | 2 | PF00052 | |
| Domain | - | 8.57e-04 | 8 | 105 | 2 | 3.90.290.10 | |
| Domain | LamB | 8.57e-04 | 8 | 105 | 2 | SM00281 | |
| Domain | Laminin_IV | 8.57e-04 | 8 | 105 | 2 | IPR000034 | |
| Domain | GPS | 9.10e-04 | 34 | 105 | 3 | SM00303 | |
| Domain | GPS | 9.91e-04 | 35 | 105 | 3 | PF01825 | |
| Domain | GPS | 1.08e-03 | 36 | 105 | 3 | PS50221 | |
| Domain | PH_dom-spectrin-type | 1.10e-03 | 9 | 105 | 2 | IPR001605 | |
| Domain | Integin_beta_N | 1.10e-03 | 9 | 105 | 2 | IPR033760 | |
| Domain | TB | 1.10e-03 | 9 | 105 | 2 | PS51364 | |
| Domain | TB_dom | 1.10e-03 | 9 | 105 | 2 | IPR017878 | |
| Domain | PSI_integrin | 1.10e-03 | 9 | 105 | 2 | PF17205 | |
| Domain | GPS | 1.17e-03 | 37 | 105 | 3 | IPR000203 | |
| Domain | Znf_FYVE_PHD | 1.45e-03 | 147 | 105 | 5 | IPR011011 | |
| Domain | LDLR_class-A_CS | 1.47e-03 | 40 | 105 | 3 | IPR023415 | |
| Domain | PHD | 1.60e-03 | 89 | 105 | 4 | SM00249 | |
| Domain | Cys-rich_flank_reg_C | 1.66e-03 | 90 | 105 | 4 | IPR000483 | |
| Domain | LRRCT | 1.66e-03 | 90 | 105 | 4 | SM00082 | |
| Domain | Pentaxin-related | 1.67e-03 | 11 | 105 | 2 | IPR001759 | |
| Domain | Pentaxin | 1.67e-03 | 11 | 105 | 2 | PF00354 | |
| Domain | Znf_PHD | 1.73e-03 | 91 | 105 | 4 | IPR001965 | |
| Domain | Pept_M10_metallopeptidase | 1.81e-03 | 43 | 105 | 3 | IPR001818 | |
| Domain | PSI | 1.93e-03 | 44 | 105 | 3 | IPR016201 | |
| Domain | TIL | 1.99e-03 | 12 | 105 | 2 | PF01826 | |
| Domain | C8 | 1.99e-03 | 12 | 105 | 2 | PF08742 | |
| Domain | ZF_PHD_2 | 2.03e-03 | 95 | 105 | 4 | PS50016 | |
| Domain | Ldl_recept_a | 2.06e-03 | 45 | 105 | 3 | PF00057 | |
| Domain | ZF_PHD_1 | 2.11e-03 | 96 | 105 | 4 | PS01359 | |
| Domain | PSI | 2.20e-03 | 46 | 105 | 3 | SM00423 | |
| Domain | - | 2.20e-03 | 46 | 105 | 3 | 4.10.400.10 | |
| Domain | CUB | 2.64e-03 | 49 | 105 | 3 | PF00431 | |
| Domain | LDrepeatLR_classA_rpt | 2.64e-03 | 49 | 105 | 3 | IPR002172 | |
| Domain | LDLa | 2.64e-03 | 49 | 105 | 3 | SM00192 | |
| Domain | CUB | 2.79e-03 | 50 | 105 | 3 | SM00042 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 3.77e-08 | 39 | 71 | 6 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 3.77e-08 | 39 | 71 | 6 | MM15165 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 1.13e-06 | 68 | 71 | 6 | M27303 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.77e-05 | 109 | 71 | 6 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.97e-05 | 111 | 71 | 6 | M27416 | |
| Pathway | WP_FOCAL_ADHESION | 6.23e-05 | 199 | 71 | 7 | M39402 | |
| Pathway | KEGG_FOCAL_ADHESION | 6.23e-05 | 199 | 71 | 7 | M7253 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 8.17e-05 | 143 | 71 | 6 | M27275 | |
| Pathway | WP_COMPLEMENT_SYSTEM | 1.20e-04 | 96 | 71 | 5 | M39581 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 2.18e-04 | 59 | 71 | 4 | M27218 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ALTERNATIVE_PATHWAY_OF_COMPLEMENT_CASCADE_C3B_BREAKDOWN | 2.48e-04 | 5 | 71 | 2 | M47875 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 2.57e-04 | 250 | 71 | 7 | M27554 | |
| Pathway | WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE | 2.60e-04 | 25 | 71 | 3 | M39713 | |
| Pathway | WP_FOCAL_ADHESION | 3.52e-04 | 187 | 71 | 6 | MM15913 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_COMPLEMENT_CASCADE_CFHR | 3.70e-04 | 6 | 71 | 2 | M47880 | |
| Pathway | KEGG_COMPLEMENT_AND_COAGULATION_CASCADES | 3.99e-04 | 69 | 71 | 4 | M16894 | |
| Pathway | REACTOME_TRANSPORT_OF_RCBL_WITHIN_THE_BODY | 5.17e-04 | 7 | 71 | 2 | MM15703 | |
| Pathway | WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4 | 5.99e-04 | 33 | 71 | 3 | M39455 | |
| Pathway | REACTOME_TRANSPORT_OF_RCBL_WITHIN_THE_BODY | 6.87e-04 | 8 | 71 | 2 | M45025 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 7.65e-04 | 300 | 71 | 7 | M610 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 8.41e-04 | 37 | 71 | 3 | M27134 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 8.41e-04 | 84 | 71 | 4 | M7098 | |
| Pathway | WP_BREAST_CANCER_PATHWAY | 1.06e-03 | 154 | 71 | 5 | M39739 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FLNA CDK12 ESYT1 SPEG OBSCN LAMC3 PLXNB2 ADGRA2 ABCA7 AHDC1 PPP1R26 JAG2 NHSL1 TMEM129 MEGF8 ADAMTS7 SETD5 CDK13 CCDC3 PKD1 | 2.29e-10 | 1105 | 109 | 20 | 35748872 |
| Pubmed | Insights on ADAMTS proteases and ADAMTS-like proteins from mammalian genetics. | 4.43e-08 | 12 | 109 | 4 | 25770910 | |
| Pubmed | 1.39e-07 | 75 | 109 | 6 | 20637190 | ||
| Pubmed | 5.95e-07 | 6 | 109 | 3 | 18541031 | ||
| Pubmed | 1.09e-06 | 332 | 109 | 9 | 37433992 | ||
| Pubmed | 1.59e-06 | 257 | 109 | 8 | 16335952 | ||
| Pubmed | Risk of non-Hodgkin lymphoma in association with germline variation in complement genes. | 2.69e-06 | 31 | 109 | 4 | 19344414 | |
| Pubmed | Analysis of the Tropism of SARS-CoV-2 Based on the Host Interactome of the Spike Protein. | 2.69e-06 | 31 | 109 | 4 | 37939376 | |
| Pubmed | 3.54e-06 | 10 | 109 | 3 | 11167130 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 16299065 | ||
| Pubmed | Human CDK12 and CDK13, multi-tasking CTD kinases for the new millenium. | 9.73e-06 | 2 | 109 | 2 | 30319007 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 31345467 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 29272322 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 24999027 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 38960036 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 20133782 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 26892043 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 10894157 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 24170107 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 38526177 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 19213840 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 16103736 | ||
| Pubmed | CDK12 is a transcription elongation-associated CTD kinase, the metazoan ortholog of yeast Ctk1. | 9.73e-06 | 2 | 109 | 2 | 20952539 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 2977721 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 15634279 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 28487468 | ||
| Pubmed | Maternofetal transport of vitamin B12: role of TCblR/CD320 and megalin. | 9.73e-06 | 2 | 109 | 2 | 28351841 | |
| Pubmed | Homozygosity mapping of a Weill-Marchesani syndrome locus to chromosome 19p13.3-p13.2. | 9.73e-06 | 2 | 109 | 2 | 11941487 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 15185077 | ||
| Pubmed | Localization of blood proteins thrombospondin1 and ADAMTS13 to cerebral corpora amylacea. | 9.73e-06 | 2 | 109 | 2 | 19422532 | |
| Pubmed | The macrophage mannose receptor promotes uptake of ADAMTS13 by dendritic cells. | 9.73e-06 | 2 | 109 | 2 | 22289891 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 25561469 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 36130933 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 16533881 | ||
| Pubmed | Dual Inhibition of CDK12/CDK13 Targets Both Tumor and Immune Cells in Ovarian Cancer. | 9.73e-06 | 2 | 109 | 2 | 35857807 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 23430977 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 34134958 | ||
| Pubmed | New genetic associations detected in a host response study to hepatitis B vaccine. | SIGLEC12 CFH KIF12 LAMC3 CFHR5 CR1 ITGB3 F13B JAG2 FCGBP SIGLEC7 C4BPB | 1.11e-05 | 824 | 109 | 12 | 20237496 |
| Pubmed | High-throughput analyses of hnRNP H1 dissects its multi-functional aspect. | ADAM15 ZNF212 NTN3 OBSCN RTL10 FAM131A AHDC1 ADAMTS10 TMEM129 MEGF8 HES7 INAVA RELT | 1.93e-05 | 1021 | 109 | 13 | 26760575 |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 24048760 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 29729689 | ||
| Pubmed | Thrombospondin-1 and ADAMTS13 competitively bind to VWF A2 and A3 domains in vitro. | 2.91e-05 | 3 | 109 | 2 | 20705333 | |
| Pubmed | Novel pathogenic variants and multiple molecular diagnoses in neurodevelopmental disorders. | 2.91e-05 | 3 | 109 | 2 | 31238879 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 16611690 | ||
| Pubmed | Gain-of-Function Mutation in Filamin A Potentiates Platelet Integrin αIIbβ3 Activation. | 2.91e-05 | 3 | 109 | 2 | 28428218 | |
| Pubmed | ADAM-15 inhibits wound healing in human intestinal epithelial cell monolayers. | 2.91e-05 | 3 | 109 | 2 | 15358598 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 33152401 | ||
| Pubmed | CR1, ABCA7, and APOE genes affect the features of cognitive impairment in Alzheimer's disease. | 2.91e-05 | 3 | 109 | 2 | 24530172 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 18697739 | ||
| Pubmed | β3 integrin-EGF receptor cross-talk activates p190RhoGAP in mouse mammary gland epithelial cells. | 2.91e-05 | 3 | 109 | 2 | 21937717 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 22268819 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 25712208 | ||
| Pubmed | USP9x-mediated deubiquitination of EFA6 regulates de novo tight junction assembly. | 2.91e-05 | 3 | 109 | 2 | 20339350 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 22672426 | ||
| Pubmed | An integrin receptor on normal and thrombasthenic platelets that binds thrombospondin. | 2.91e-05 | 3 | 109 | 2 | 2478219 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 2010551 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 3782802 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 37438087 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 31474762 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 18375753 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 25849143 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 21531776 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 20702729 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 9988761 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 27143357 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 31409673 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 22514678 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 18979363 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 23152903 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 37026485 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 27479907 | ||
| Pubmed | 3.64e-05 | 59 | 109 | 4 | 21421844 | ||
| Pubmed | ISLR2 CDK12 ZNF212 PHRF1 ADGRA2 TUBGCP6 ZFYVE28 CAMKK2 RAB11FIP5 | 4.52e-05 | 529 | 109 | 9 | 14621295 | |
| Pubmed | 5.82e-05 | 4 | 109 | 2 | 21224474 | ||
| Pubmed | 5.82e-05 | 4 | 109 | 2 | 27165610 | ||
| Pubmed | 5.82e-05 | 4 | 109 | 2 | 38990656 | ||
| Pubmed | 5.82e-05 | 4 | 109 | 2 | 27494323 | ||
| Pubmed | 5.82e-05 | 4 | 109 | 2 | 37460871 | ||
| Pubmed | 5.82e-05 | 4 | 109 | 2 | 24391502 | ||
| Pubmed | 5.82e-05 | 4 | 109 | 2 | 38454157 | ||
| Pubmed | Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells. | 5.82e-05 | 4 | 109 | 2 | 30130255 | |
| Pubmed | Complement C3b contributes to Escherichia coli-induced platelet aggregation in human whole blood. | 5.82e-05 | 4 | 109 | 2 | 36591264 | |
| Pubmed | Siglec receptors impact mammalian lifespan by modulating oxidative stress. | 5.82e-05 | 4 | 109 | 2 | 25846707 | |
| Pubmed | Validating GWAS Variants from Microglial Genes Implicated in Alzheimer's Disease. | 5.82e-05 | 4 | 109 | 2 | 28477215 | |
| Pubmed | An integrin β₃-KRAS-RalB complex drives tumour stemness and resistance to EGFR inhibition. | 5.82e-05 | 4 | 109 | 2 | 24747441 | |
| Pubmed | Immunosuppressive Siglec-E ligands on mouse aorta are up-regulated by LPS via NF-κB pathway. | 5.82e-05 | 4 | 109 | 2 | 31918287 | |
| Pubmed | 5.82e-05 | 4 | 109 | 2 | 22012619 | ||
| Pubmed | 5.82e-05 | 4 | 109 | 2 | 19552697 | ||
| Pubmed | 5.82e-05 | 4 | 109 | 2 | 37467314 | ||
| Pubmed | 5.82e-05 | 4 | 109 | 2 | 37492129 | ||
| Pubmed | 5.82e-05 | 4 | 109 | 2 | 7775583 | ||
| Pubmed | 5.82e-05 | 4 | 109 | 2 | 22505472 | ||
| Pubmed | 5.82e-05 | 4 | 109 | 2 | 33007530 | ||
| Pubmed | 5.82e-05 | 4 | 109 | 2 | 27920204 | ||
| Pubmed | 5.82e-05 | 4 | 109 | 2 | 21835922 | ||
| Pubmed | 5.82e-05 | 4 | 109 | 2 | 34155121 | ||
| Pubmed | Polysialic acid and Siglec-E orchestrate negative feedback regulation of microglia activation. | 5.82e-05 | 4 | 109 | 2 | 32725371 | |
| Pubmed | 5.82e-05 | 4 | 109 | 2 | 20301293 | ||
| Pubmed | 5.82e-05 | 4 | 109 | 2 | 30910970 | ||
| Pubmed | 5.82e-05 | 4 | 109 | 2 | 34563268 | ||
| Cytoband | 1q32 | 2.22e-04 | 49 | 109 | 3 | 1q32 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 2.66e-09 | 57 | 72 | 7 | 1179 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 8.56e-07 | 19 | 72 | 4 | 50 | |
| GeneFamily | Complement system|Sushi domain containing | 3.93e-04 | 36 | 72 | 3 | 492 | |
| GeneFamily | PHD finger proteins | 4.56e-04 | 90 | 72 | 4 | 88 | |
| GeneFamily | Laminin subunits | 1.01e-03 | 12 | 72 | 2 | 626 | |
| GeneFamily | Gap junction proteins | 3.43e-03 | 22 | 72 | 2 | 314 | |
| GeneFamily | Cyclin dependent kinases | 4.78e-03 | 26 | 72 | 2 | 496 | |
| GeneFamily | CD molecules|C2-set domain containing|Sialic acid binding Ig like lectins | 5.53e-03 | 28 | 72 | 2 | 745 | |
| GeneFamily | CD molecules|Tetraspanins | 7.62e-03 | 33 | 72 | 2 | 768 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.36e-07 | 196 | 109 | 9 | M3008 | |
| Coexpression | NABA_MATRISOME | ADAM15 NTN3 KCP LAMC2 LAMC3 ADAMTS13 PLXNB2 SSPOP SVEP1 F13B ADAMTS10 THBS1 MEGF8 ADAMTS7 ADAMTS20 LTBP2 MEGF11 FBN3 | 2.32e-07 | 1026 | 109 | 18 | M5889 |
| Coexpression | NABA_MATRISOME | ADAM15 NTN3 KCP LAMC2 LAMC3 ADAMTS13 PLXNB2 SSPOP SVEP1 F13B ADAMTS10 THBS1 MEGF8 ADAMTS7 ADAMTS20 LTBP2 MEGF11 | 9.00e-07 | 1008 | 109 | 17 | MM17056 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.39e-06 | 191 | 109 | 8 | MM17059 | |
| Coexpression | NABA_CORE_MATRISOME | 2.31e-06 | 275 | 109 | 9 | M5884 | |
| Coexpression | PRC1_BMI_UP.V1_DN | 1.36e-05 | 187 | 109 | 7 | M2730 | |
| Coexpression | NABA_CORE_MATRISOME | 1.77e-05 | 270 | 109 | 8 | MM17057 | |
| Coexpression | GSE36078_UNTREATED_VS_AD5_INF_MOUSE_LUNG_DC_UP | 2.09e-05 | 200 | 109 | 7 | M9289 | |
| Coexpression | PEREZ_TP53_TARGETS | PHRF1 OBSCN DVL3 RTL10 KCP ABCA7 AHDC1 JAG2 TUBGCP6 ZFYVE28 ADAMTS7 CCDC3 INAVA ARHGAP27 MEGF11 PEAR1 | 3.68e-05 | 1201 | 109 | 16 | M4391 |
| Coexpression | NIKOLSKY_BREAST_CANCER_22Q13_AMPLICON | 4.56e-05 | 17 | 109 | 3 | M12053 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_COLORECTAL_TUMOR | 1.08e-04 | 59 | 109 | 4 | M47989 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Mesofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.86e-07 | 198 | 109 | 7 | 0cd930e374c2c48d1991b51c025f9801b22ecee7 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Mesofibroblastic-Mesothelia|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.86e-07 | 198 | 109 | 7 | e0df6d6ff2a9c41d813f84a2a5ee7cb5f6fc3e30 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.06e-07 | 199 | 109 | 7 | dfc5c7a4a093baa7158dd8d4d29a870d9c469a3f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.06e-07 | 199 | 109 | 7 | c1760581c34b81d1d92c67500a1c8944e9cc6dad | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.82e-06 | 149 | 109 | 6 | 768877bade04ca0321593b8470b5011ad8270431 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.38e-06 | 156 | 109 | 6 | d5207dbfbcfb885557ea1378dfe6a56d7102e94a | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.38e-06 | 156 | 109 | 6 | 363f1b661048d25895e2b8681c82894c957b29c0 | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Spp1_Col15a1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.66e-06 | 159 | 109 | 6 | 34c90711c5857cf6ada7b3acff99f1d48c7caf29 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.91e-06 | 170 | 109 | 6 | d7c9a604311974ff87ece43a0f8725a234d262f7 | |
| ToppCell | Bronchial_Biopsy-Endothelial-Lymphatic|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.18e-06 | 172 | 109 | 6 | c41f5a66781bbf63afce7ca5d118cc6d8e0fe0bc | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D231|Adult / Lineage, Cell type, age group and donor | 4.18e-06 | 172 | 109 | 6 | 858cee96c1c06160863b4adcd7023c0d678bd50f | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.26e-06 | 179 | 109 | 6 | 056df2aaff750e0e283e7da78fcc3c90c366aac0 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.26e-06 | 179 | 109 | 6 | f5f3945ef3b9efc5921a71fd51deeb2c80f0ce11 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.97e-06 | 183 | 109 | 6 | 667717366cb181b8a04a347e64f0f5a4dfc6ee7f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.96e-06 | 188 | 109 | 6 | ccddc08121caff958a2b6f9e278a018858af6b4d | |
| ToppCell | Substantia_nigra-Endothelial|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 7.18e-06 | 189 | 109 | 6 | bef8234bd9c4d6e3cdef0791d8066b39ba56ebba | |
| ToppCell | Hippocampus-Endothelial|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.85e-06 | 192 | 109 | 6 | 36deadab892d3e639a71f33697bb2d3cbbaa5372 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 8.33e-06 | 194 | 109 | 6 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.58e-06 | 195 | 109 | 6 | edd4cd8402af81737b2074f9dce71cc6ab09be7e | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.83e-06 | 196 | 109 | 6 | 147dc1ca5942df48a083cce39a9a7541430f8365 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.83e-06 | 196 | 109 | 6 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.83e-06 | 196 | 109 | 6 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.83e-06 | 196 | 109 | 6 | ee89f6884aea11aefeaabe043db7f80145dcdf7f | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-mesothelial_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.83e-06 | 196 | 109 | 6 | e75c36cb042342d69a593fb1ce62fab033889871 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.36e-06 | 198 | 109 | 6 | 7dd874b09c81cc512ccc1e9b65f290a5f94d736e | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.36e-06 | 198 | 109 | 6 | 7d2fe57e0f9311ac1e6854402ebc154306eb1ba5 | |
| ToppCell | Bronchial-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.63e-06 | 199 | 109 | 6 | 929f809579368201331d9099d8904b6e3c41797b | |
| ToppCell | Bronchial-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.63e-06 | 199 | 109 | 6 | 854628ce91068093c14bd4d45ba38c41469f3549 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_2-TYR-L2-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.91e-06 | 200 | 109 | 6 | 04954fbe1e2264077228bb582c9a5897a70e6da2 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.91e-06 | 200 | 109 | 6 | 913487e065dd580c9cbcbb3c3fc76a8d446f8856 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_2-TYR|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.91e-06 | 200 | 109 | 6 | bfdafb024a7b20d46837b2e6480dd4929253cd62 | |
| ToppCell | (01)_IL1RL1+|World / shred by cell type by condition | 9.91e-06 | 200 | 109 | 6 | 501420901bf3ec1b050e0d14596a9f9f3fdfc928 | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Osr1_Mc5r|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.84e-05 | 168 | 109 | 5 | 9930bd63b60c03f0152838a79eef77da1c2dd8e5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.84e-05 | 168 | 109 | 5 | d19a115365c5415e51c039718d7669de788fcf33 | |
| ToppCell | COVID-19_Severe-CD4+_CTL|World / disease group, cell group and cell class | 6.01e-05 | 169 | 109 | 5 | 8c8168ac93a808d7b4756e4491db2b2979df1c1f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.01e-05 | 169 | 109 | 5 | a84490724a206c9bbb145f7ce08613f91d100ac4 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.18e-05 | 170 | 109 | 5 | a78d9789c3e7c84a36e1bd380192d7aba4a4d443 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.18e-05 | 170 | 109 | 5 | ff68600b945b3a5437b14e5411b3db800d0ccbe5 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.35e-05 | 171 | 109 | 5 | a4a2c5dc995589fbe3d4ca6ee1df888807e4ae34 | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.35e-05 | 171 | 109 | 5 | 2e43fb129ee9bdc3b31febc43c10f959bf0f4a7d | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.35e-05 | 171 | 109 | 5 | e219a1aa59a96e4bc3e2eacf985679174a51de41 | |
| ToppCell | droplet-Liver-nan-3m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.53e-05 | 172 | 109 | 5 | 1f335ccb92b22d0412954e8fc3af212f96410b67 | |
| ToppCell | droplet-Liver-nan-3m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.53e-05 | 172 | 109 | 5 | bb96c896d125e10b71e94e2bdad243899045af5c | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.71e-05 | 173 | 109 | 5 | 6d2ceba4f89a228600e2b40aba81bb0eb81578c0 | |
| ToppCell | droplet-Thymus-nan-24m-Myeloid-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.89e-05 | 174 | 109 | 5 | 44c21521991ad4789783d73d5aa4993a22876886 | |
| ToppCell | primary_visual_cortex-Non-neuronal-leptomeningeal_cell|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.89e-05 | 174 | 109 | 5 | 2891ab2fd05eb4bbd239d1a2865f21ef7f2df39e | |
| ToppCell | primary_visual_cortex-Non-neuronal-leptomeningeal_cell-VLMC|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.89e-05 | 174 | 109 | 5 | eade55f86ef1f7a5355ad65cec3aa6bfc5d3c62d | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Dedifferentiated_Liposarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 7.08e-05 | 175 | 109 | 5 | 2eca4c168dea2017ea0e383006e28abed22f32ec | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.08e-05 | 175 | 109 | 5 | 711ace94fa9a763c6ae48171a690953f25deebe4 | |
| ToppCell | NS-critical-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.28e-05 | 176 | 109 | 5 | 7cf1a06ceee1ec06532f44c729c31b4d58e5ea49 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.28e-05 | 176 | 109 | 5 | b4a23d8d1414434adeb237a96f28c825f1aebd77 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.28e-05 | 176 | 109 | 5 | 66c9c6b59030f67e8d746a9c6930e50923f2ded1 | |
| ToppCell | COVID-19_Severe-CD4+_CTL|COVID-19_Severe / disease group, cell group and cell class | 7.47e-05 | 177 | 109 | 5 | 34e9455790bae905dd91923792f4109d18b7686e | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.47e-05 | 177 | 109 | 5 | 1cb78133ac09ea3a3f5b5de07151033998406512 | |
| ToppCell | facs-Brain_Myeloid-Striatum-24m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.47e-05 | 177 | 109 | 5 | f6b9d91d46830d0d207b0abd4ee5a4942fd99774 | |
| ToppCell | primary_visual_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Osr1_Mc5r|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.47e-05 | 177 | 109 | 5 | 599cf7f5b774e197a1b43c98e4b9a8c1a618f38a | |
| ToppCell | PND14-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.68e-05 | 178 | 109 | 5 | 63f5880a5b514e20ef2c07a6a9cb8df34e6cede5 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.68e-05 | 178 | 109 | 5 | 82c84f8b8a7e6a3d3be3351b348a37143279c100 | |
| ToppCell | droplet-Fat-Scat-21m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.68e-05 | 178 | 109 | 5 | 5fc9f41609735b972a2cd0830182d13742cd5bf5 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Megakaryocyte/Platelet|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.68e-05 | 178 | 109 | 5 | cb91558469ae0748106fb0b6d702edb0ff21a884 | |
| ToppCell | facs-Heart-RA-24m-Myeloid-macrophage|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.30e-05 | 181 | 109 | 5 | c68d272eb41f81bd8ea4d0360733a2396bc87037 | |
| ToppCell | facs-Heart-RA-24m-Myeloid-macrophage|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.30e-05 | 181 | 109 | 5 | 5e5eb89f224ee48065a328ade030cbc4dcdcac12 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.30e-05 | 181 | 109 | 5 | 35bcdcd2651149692e5b150e887c0f450c81d2d4 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 8.30e-05 | 181 | 109 | 5 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | droplet-Thymus-nan-18m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.52e-05 | 182 | 109 | 5 | f6717e97e87513384149800c9fd8dea821ab9393 | |
| ToppCell | droplet-Thymus-nan-18m-Myeloid-professional_antigen_presenting_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.52e-05 | 182 | 109 | 5 | c33b0d532822186a1e8e645500347972468718c0 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D122|Adult / Lineage, Cell type, age group and donor | 8.75e-05 | 183 | 109 | 5 | fc31a43a637423cb3bb9aa184a3a889a0b9aaea6 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.75e-05 | 183 | 109 | 5 | 5e361be3ae3fe05098968e58427630127bd12675 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.97e-05 | 184 | 109 | 5 | cb15d6bae52c5ec251c2235859dc7e65f630ae23 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.97e-05 | 184 | 109 | 5 | bde4eaabd3e9bdaed23867d23a919b9d84b52d4b | |
| ToppCell | facs-Lung-EPCAM-24m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.44e-05 | 186 | 109 | 5 | 3c4994a1a7db06a61da8170e45e06aaef7896592 | |
| ToppCell | facs-Lung-EPCAM-24m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.44e-05 | 186 | 109 | 5 | a583d6fc0f1e729f6e9fd18d7b49d6eab9ca32b9 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell|Adult / Lineage, Cell type, age group and donor | 9.68e-05 | 187 | 109 | 5 | 62759efb660179402fb574ce5701c89a2e17bcfe | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.68e-05 | 187 | 109 | 5 | 4e553721fa5598cb211f44e3226280b7e6885484 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.68e-05 | 187 | 109 | 5 | d36e7fc6125e7a4310499365022d38f34b757a73 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.68e-05 | 187 | 109 | 5 | 827eae63fabf6892a82ce7779b5f395958d3d628 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.68e-05 | 187 | 109 | 5 | 25efb82afe863a853ecdd781ad89026c993aaa67 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.93e-05 | 188 | 109 | 5 | b382d18fb09fb2869f3c151efa71540a7f5ed229 | |
| ToppCell | Frontal_cortex-Endothelial|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 9.93e-05 | 188 | 109 | 5 | a43392dbd10fc7dbfb31be39b8af8a7ea121c894 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.93e-05 | 188 | 109 | 5 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 9.93e-05 | 188 | 109 | 5 | c90669b51e1902fe7726555290c91c92a911df83 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-04 | 189 | 109 | 5 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-04 | 189 | 109 | 5 | 4eea4759520c312bd17a681034d8074e47093d2b | |
| ToppCell | Globus_pallidus-Endothelial|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.02e-04 | 189 | 109 | 5 | ad7dc9d25edd68fb624380a082c389fe7d640e7d | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 189 | 109 | 5 | 6f0fc5271a7d3682f145e734abc3be6473dda2e2 | |
| ToppCell | Striatum-Endothelial|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.02e-04 | 189 | 109 | 5 | 95ee3b6d7fbbfcf91c780dfcd0926acec05f0a2d | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 189 | 109 | 5 | 3b9ce8964b16cb2200d30cbb0bfc711dcad2380e | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 189 | 109 | 5 | 38acb307907fde68b992057714448c1561d69ee3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 190 | 109 | 5 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 190 | 109 | 5 | e2fdbfaf08da3274b6bdda615386aa880040a90a | |
| ToppCell | 10x5'v1-week_12-13-Endothelial-stroma-tip_EC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.07e-04 | 191 | 109 | 5 | cf1a67b7c0d5c0dc5d4d59faf9d9b1a3a1fb00e0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-04 | 191 | 109 | 5 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-3|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.07e-04 | 191 | 109 | 5 | 80d30d8eedb4c70b58440646325bc04c5700803e | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-Myofibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.07e-04 | 191 | 109 | 5 | aa43b472bc8362f79ae63f09f1ca764718bbf22c | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 1.07e-04 | 191 | 109 | 5 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 191 | 109 | 5 | 2f733d510a4862565a817f59829d8387d7ea26d9 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 191 | 109 | 5 | 8691eba35793e4e90f93d50c2145847ee51289f7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-04 | 191 | 109 | 5 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.10e-04 | 192 | 109 | 5 | 67e845e513e76e820f55e2f0d15eb16f2944d05c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.10e-04 | 192 | 109 | 5 | 09cb5b89a164ac7444774ccc8c90323c8ea2026b | |
| Drug | Nefopam hydrochloride [23327-57-3]; Up 200; 13.8uM; MCF7; HT_HG-U133A | IL17RC ADGRA2 ITGB3 GJA8 THBS1 CAMKK2 SIGLEC7 ADAMTS7 ADAMTS20 SLC14A2 | 2.90e-08 | 197 | 106 | 10 | 3627_UP |
| Drug | Colchicine [64-86-8]; Up 200; 10uM; MCF7; HT_HG-U133A | 3.17e-07 | 194 | 106 | 9 | 3213_UP | |
| Drug | Pindolol [13523-86-9]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 3.98e-06 | 197 | 106 | 8 | 2238_UP | |
| Drug | Theophylline monohydrate [5967-84-0]; Up 200; 20.2uM; MCF7; HT_HG-U133A | 4.13e-06 | 198 | 106 | 8 | 3326_UP | |
| Drug | Mianserine hydrochloride [21535-47-7]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 2.96e-05 | 189 | 106 | 7 | 2231_UP | |
| Drug | Oxalamine citrate salt [1949-20-8]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 3.39e-05 | 193 | 106 | 7 | 3344_UP | |
| Drug | 5707885; Up 200; 50uM; MCF7; HT_HG-U133A | 3.50e-05 | 194 | 106 | 7 | 6385_UP | |
| Drug | Ifenprodil tartrate [23210-58-4]; Down 200; 8.4uM; HL60; HT_HG-U133A | 3.74e-05 | 196 | 106 | 7 | 2372_DN | |
| Drug | Piperacillin sodium salt [59703-84-3]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 3.86e-05 | 197 | 106 | 7 | 3939_UP | |
| Drug | Indapamide [26807-65-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 3.86e-05 | 197 | 106 | 7 | 3859_UP | |
| Drug | (+) -Levobunolol hydrochloride [47141-41-3]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 3.86e-05 | 197 | 106 | 7 | 3355_UP | |
| Drug | NSC-270916 | 4.08e-05 | 82 | 106 | 5 | CID000002949 | |
| Drug | Flecainide acetate [54143-56-5]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 4.25e-05 | 200 | 106 | 7 | 3418_UP | |
| Drug | Oxymetazoline hydrochloride [2315-02-8]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 4.25e-05 | 200 | 106 | 7 | 2278_UP | |
| Drug | Grgds | 4.33e-05 | 83 | 106 | 5 | CID000123811 | |
| Disease | Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 measurement | 1.70e-07 | 4 | 104 | 3 | EFO_0803113 | |
| Disease | cortical surface area measurement | UPK1A ADAM15 LAMC3 XKR6 PLXNB2 ADGRA2 SVEP1 JAG2 TYR NHSL1 THBS1 EGFR ADAMTS7 CCDC3 PKD1 ADAMTS20 ARHGAP27 FBN3 | 1.03e-06 | 1345 | 104 | 18 | EFO_0010736 |
| Disease | atypical hemolytic-uremic syndrome (is_marker_for) | 3.68e-05 | 3 | 104 | 2 | DOID:0080301 (is_marker_for) | |
| Disease | Weill-Marchesani syndrome | 3.68e-05 | 3 | 104 | 2 | C0265313 | |
| Disease | complement C5 measurement | 3.68e-05 | 3 | 104 | 2 | EFO_0020278 | |
| Disease | thrombospondin type-1 domain-containing protein 7A measurement | 3.68e-05 | 3 | 104 | 2 | EFO_0803150 | |
| Disease | platelet-derived growth factor receptor alpha measurement | 3.68e-05 | 3 | 104 | 2 | EFO_0021844 | |
| Disease | Weill-Marchesani Syndrome, Autosomal Dominant | 3.68e-05 | 3 | 104 | 2 | C1869115 | |
| Disease | Weill-Marchesani Syndrome, Autosomal Recessive | 3.68e-05 | 3 | 104 | 2 | C1869114 | |
| Disease | Schizophrenia | PSD CHD4 CSMD2 ITGB3 JAG2 TYR GJA8 THBS1 CAMKK2 STON2 LRP2 ZNF565 | 6.64e-05 | 883 | 104 | 12 | C0036341 |
| Disease | semaphorin-6A measurement | 7.35e-05 | 4 | 104 | 2 | EFO_0020721 | |
| Disease | Weill-Marchesani syndrome | 7.35e-05 | 4 | 104 | 2 | cv:C0265313 | |
| Disease | Weill-Marchesani syndrome (is_implicated_in) | 7.35e-05 | 4 | 104 | 2 | DOID:0050475 (is_implicated_in) | |
| Disease | creatinine measurement | CFH CDK12 SPEG OBSCN PHF7 PLXNB2 LACTB JAG2 ADAMTS7 LRP2 SLC14A2 PSD4 | 2.03e-04 | 995 | 104 | 12 | EFO_0004518 |
| Disease | sialic acid-binding Ig-like lectin 6 measurement | 3.40e-04 | 8 | 104 | 2 | EFO_0008285 | |
| Disease | tumor necrosis factor receptor superfamily member 19L measurement | 3.40e-04 | 8 | 104 | 2 | EFO_0008309 | |
| Disease | Malignant neoplasm of breast | FLNA OBSCN DVL3 PHF7 FAM131A CFHR5 PGR JAG2 THBS1 EGFR FASTKD3 ZNF541 | 4.05e-04 | 1074 | 104 | 12 | C0006142 |
| Disease | sialic acid-binding Ig-like lectin 9 measurement | 4.36e-04 | 9 | 104 | 2 | EFO_0008286 | |
| Disease | C3 glomerulopathy | 4.36e-04 | 9 | 104 | 2 | C4087273 | |
| Disease | plexin-B2 measurement | 4.36e-04 | 9 | 104 | 2 | EFO_0021867 | |
| Disease | complement factor H-related protein 5 measurement | 4.42e-04 | 42 | 104 | 3 | EFO_0008098 | |
| Disease | platelet aggregation | 5.42e-04 | 45 | 104 | 3 | GO_0070527 | |
| Disease | cortical thickness | LAMC3 XKR6 ADGRA2 JAG2 NHSL1 THBS1 EGFR ADAMTS7 SETD5 BAZ1A PKD1 ADAMTS20 | 5.55e-04 | 1113 | 104 | 12 | EFO_0004840 |
| Disease | corneal topography | 6.10e-04 | 109 | 104 | 4 | EFO_0004345 | |
| Disease | myopathy (implicated_via_orthology) | 6.56e-04 | 48 | 104 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | hemopexin measurement | 6.63e-04 | 11 | 104 | 2 | EFO_0008149 | |
| Disease | Sensory hearing loss | 6.63e-04 | 11 | 104 | 2 | C1691779 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 6.97e-04 | 49 | 104 | 3 | DOID:3910 (is_implicated_in) | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 8.77e-04 | 53 | 104 | 3 | C4707243 | |
| Disease | interleukin-1 beta measurement | 9.26e-04 | 54 | 104 | 3 | EFO_0004812 | |
| Disease | complement factor H-related protein 1 measurement | 1.03e-03 | 56 | 104 | 3 | EFO_0600054 | |
| Disease | membranous glomerulonephritis (biomarker_via_orthology) | 1.09e-03 | 14 | 104 | 2 | DOID:10976 (biomarker_via_orthology) | |
| Disease | myeloid cell surface antigen CD33 measurement | 1.25e-03 | 15 | 104 | 2 | EFO_0008238 | |
| Disease | Proteinuria | 1.25e-03 | 15 | 104 | 2 | HP_0000093 | |
| Disease | skin pigmentation | 1.88e-03 | 69 | 104 | 3 | EFO_0003784 | |
| Disease | systemic lupus erythematosus | 2.08e-03 | 799 | 104 | 9 | MONDO_0007915 | |
| Disease | Endometrial Carcinoma | 2.13e-03 | 72 | 104 | 3 | C0476089 | |
| Disease | coagulation factor measurement | 2.24e-03 | 20 | 104 | 2 | EFO_0004634 | |
| Disease | COVID-19 (is_implicated_in) | 2.47e-03 | 21 | 104 | 2 | DOID:0080600 (is_implicated_in) | |
| Disease | nephrosis (biomarker_via_orthology) | 2.71e-03 | 22 | 104 | 2 | DOID:2527 (biomarker_via_orthology) | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 2.87e-03 | 80 | 104 | 3 | DOID:12930 (implicated_via_orthology) | |
| Disease | Sensorineural Hearing Loss (disorder) | 2.97e-03 | 23 | 104 | 2 | C0018784 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SEICFPTVPGCPGAW | 601 | Q9BSJ8 | |
| ELISRLCGSPCPAVW | 946 | Q9NYV4 | |
| GSPRCPNCSFLPDLW | 186 | Q5SZB4 | |
| LWSSPLPRCVAECGN | 1086 | Q7Z408 | |
| TCLPNLTWSGTPPDC | 3171 | Q7Z408 | |
| ARPPGSCWDPTQCTR | 26 | Q6RUI8 | |
| VRASWRACCPPASPA | 1076 | Q96PE1 | |
| SGWQCRPTRGDCDLP | 476 | Q13444 | |
| PLVDPWIERPCCGDT | 41 | Q7L3V2 | |
| WRPLPSCEEKSCDNP | 256 | P08603 | |
| AWPCPNTVDCFVSRP | 171 | P29033 | |
| RCSPPRCWTPSEPES | 631 | Q5TGY3 | |
| RGRCWAAGPVPELCP | 321 | Q75N90 | |
| CWDPSPRGCFTLPRS | 336 | Q92997 | |
| ISRICGSPCPAVWPD | 926 | Q14004 | |
| LDWSECTPSCGPGLR | 951 | Q9H324 | |
| ACVLEPCPPYWAVGD | 736 | Q76LX8 | |
| PRPAEIWDCFTPCGE | 1196 | P59510 | |
| WPESSRPCGTEDCEP | 1616 | Q9UKP4 | |
| WTPESPSPACQCSRP | 1336 | Q8IZY2 | |
| PEGDWFCPECRPKQR | 1186 | Q9NRL2 | |
| WALLGVAGSCPEPCA | 11 | Q6UXK2 | |
| CPEWREECSFELPPG | 66 | Q9BXF6 | |
| PPEWVPDEACGFCTA | 811 | Q9HCC9 | |
| PSGLWEALTPCNGCR | 401 | Q7Z6G8 | |
| LPCTWSIGLAAEPGC | 91 | Q96H96 | |
| TPGWLGDTCELPCPD | 511 | A6BM72 | |
| LPCLCLEGWSATPDA | 176 | Q6ZVW7 | |
| WGECGAEEPPSTPCL | 946 | Q9Y219 | |
| WAPPCSPGSAKCPRE | 546 | Q96FN5 | |
| IPLTWRCDGHPDCPD | 146 | Q9NPF0 | |
| WSPQTPAPPCSRCFA | 91 | P83111 | |
| EALIPFCSPPDWCLS | 981 | Q5SYE7 | |
| QGKWSSPPVCLEPCT | 441 | P05160 | |
| GQPCSCWPRPDSVVL | 1501 | O15031 | |
| LSCGADWVFIPECPP | 221 | P08237 | |
| DPACCSPIVPRNEWK | 26 | O75594 | |
| PSEPCERPWEGPHTC | 51 | Q5VY43 | |
| RPGASWAFLSCPPED | 2166 | Q7Z7M0 | |
| PVDEWFCPECAAPGV | 221 | Q9P1Y6 | |
| CWERVGCPPGHREEP | 296 | Q96RT7 | |
| DEKDCPTQPFRCPSW | 1301 | P98164 | |
| CPWLTEEGPACSRPA | 7921 | Q5VST9 | |
| WVPAGDAACGCPRLL | 506 | O00634 | |
| PPACEVTSSWCLFGP | 131 | P06401 | |
| SPEGCWGPEPRDCVS | 511 | P00533 | |
| WEPELPSCSRVCQPP | 286 | P17927 | |
| WEPELPSCSRVCQPP | 736 | P17927 | |
| WEPELPSCSRVCQPP | 1186 | P17927 | |
| ACQLPSEWRPLSEGC | 21 | Q9BQI4 | |
| WSGSPASDCDPLCPE | 356 | Q8NFT6 | |
| WRSEELCPLSCPPHS | 1126 | Q9Y6R7 | |
| LVDSCAPGLCPDWDS | 201 | P21333 | |
| WPCPNVVDCFVSRPT | 186 | P48165 | |
| PAGSEPWLCQPAPRC | 26 | Q6UWQ7 | |
| KDCQPLCPPLTGSWE | 326 | Q6UXB0 | |
| TWAPPFPICKSRDCD | 126 | P20851 | |
| QWSEPPRCLDPCVVS | 496 | Q9BXR6 | |
| GAFWGVTLCAPCPPR | 581 | Q14767 | |
| TECPRAWQCSDVPEP | 516 | Q56NI9 | |
| WCSDEALPLGSPRCD | 51 | P05106 | |
| VRGSPCVESCWAPAP | 556 | Q96RR4 | |
| CVESCWAPAPGSPAR | 561 | Q96RR4 | |
| WEILPAMPTPRCACS | 306 | Q8IYD2 | |
| VSGAPAPWVEQCICP | 371 | Q13753 | |
| CSLCPFSPTDPGWPA | 496 | Q8NFF5 | |
| PRCAWSPSLCSPRAG | 171 | Q9BYE0 | |
| PEIPNGEWLCPRCTC | 481 | Q14839 | |
| PGWSRCPPSLLCALS | 66 | Q3KP66 | |
| CSLPAEAALCWRAPG | 391 | Q8NAC3 | |
| WRCRCPGLSGEDTIP | 566 | Q8WUT4 | |
| SWVLCDRCTPIPGGP | 1581 | P98161 | |
| TPEPKCPEDWGASSR | 641 | P22897 | |
| LPEASDDFCPGIRCW | 146 | Q9NRR2 | |
| PRSPWGDCAEPSCLC | 61 | Q8N8V8 | |
| EGDCAISPPRCPRRW | 11 | A5PKW4 | |
| DISGQVTCPPDWPCG | 1831 | A2VEC9 | |
| LIANCSSWPCAEGEP | 3171 | A2VEC9 | |
| WSPCSRSCTDPARPA | 3891 | A2VEC9 | |
| SEWSPCGPCLPPSAL | 4531 | A2VEC9 | |
| RLCPDPGACPDSCQW | 4606 | A2VEC9 | |
| KPSSGPVCWLCLREP | 26 | Q9BWX1 | |
| PTWRGPTLCVVGCPL | 1471 | Q6ZWJ8 | |
| SWPGCCSEAELEKPR | 841 | Q7RTY7 | |
| LCPWLCSRQPEPFGV | 41 | Q14CZ7 | |
| CPRGRSSVWGPPDAC | 66 | Q5JXC2 | |
| ESLPCTLAPCPWRSP | 426 | Q8NDX1 | |
| CSVAGSWVCPRPLAR | 181 | Q6ZUM4 | |
| SPNSEGETVPTWCPC | 81 | Q9C0A6 | |
| LTCSVPWACEQGTPP | 166 | Q9Y286 | |
| WEAFGPPGSCRFPRC | 16 | Q5T8A7 | |
| ITPEACTGPSPCAVW | 206 | Q6ZT89 | |
| EPALESPTCCLLWRP | 66 | Q8NAX2 | |
| LCQPDGTWSSPLPEC | 2421 | Q4LDE5 | |
| GTWSSPLPECVPVEC | 2426 | Q4LDE5 | |
| LTCSVPWACEQGTPP | 291 | Q96PQ1 | |
| PCWTCPSFDSLGRCP | 131 | Q8WXE9 | |
| VRLLCPVPSEECPTW | 321 | Q7Z7M1 | |
| TLPPLCCCGPDFWDA | 881 | Q0P6D6 | |
| PLPELLFPWTCRGCG | 306 | Q8N8E2 | |
| SCCAELLWGIPLPPD | 511 | Q5GH73 | |
| ATVPDGECCPRCWPS | 361 | P07996 | |
| VTGPWCPDLESRCEK | 111 | Q8N9K5 | |
| VADPDCRWCPAPDCG | 211 | Q9NV58 | |
| PAPEPSCLWLRRCGA | 86 | Q15772 | |
| GPSPSLRDACSLPWD | 371 | P98077 | |
| VGRAPGWAPTCCLPV | 191 | A6NE52 | |
| GWAPTCCLPVPDLRL | 196 | A6NE52 | |
| CPPWSGDRSPCGQLS | 36 | P14679 | |
| PLNCSSWLGCPEEGA | 771 | Q4G0T1 | |
| EVVFPWPPLCCRRTG | 181 | O00322 | |
| WPPDSCCVREFPGCS | 176 | O95859 | |
| TLCRPCPPGTFSAAW | 46 | Q969Z4 | |
| WGSCTPEEPEESLRP | 341 | Q9UDV6 | |
| PDTWLASRVPCPTCR | 336 | A0AVI4 | |
| GLPPCTWPFCLSALT | 856 | Q15849 | |
| MGSRPCSPSACLAPW | 1 | Q6ZRP0 | |
| SCASWLCPLPLAPGR | 56 | Q8IZ20 | |
| AECWPEGGSVPACLP | 381 | Q9H0D2 | |
| PGLSPPASWVEICSC | 661 | Q9Y6N6 |